China News Service, Haikou, July 5 (Wang Ziqian and Wang Heru) Haikou Customs announced on the 5th that Boao Airport Customs, a subsidiary of Haikou Customs, has completed the approval of special items for entry for the first imported neutralizing antibody Evusheld (Enshide) in mainland China. The total value of the goods is 21.9802 million yuan. The drug is mainly used for pre-exposure prevention of novel coronavirus pneumonia in adults and adolescents (≥12 years old, weight ≥40 kg).
Hainan Boao Lecheng International Medical Tourism Pilot Zone announced on the 4th that Evusheld has passed special import approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone.
"The approval of Evusheld in Hainan marks the world's only drug that can be used for the prevention of new coronavirus infection, and it is the first trial access in mainland China." The drug landing hospital, Boao Lecheng Ruijin Hainan Hospital, is in charge of the Technology Development Department Introduced by Wang Fang.
Hainan Boao Lecheng International Medical Tourism Pilot Zone was established with the approval of the State Council of China in 2013. It enjoys a series of special policies such as “franchised medical treatment, chartered research, franchise operation, chartered international medical exchange” and real-world data pilots. It is the Hainan Free Trade Port. Build key parks.
Huang Dan, Chief of the Comprehensive Business Section of Boao Airport Customs, said: "Under the premise of precise risk prevention and control, rapid approval of imported medical devices that are urgently needed in clinical practice will help ensure timely medication for patients and help improve the level of medical services in Lecheng." (End)